Traynor Capital Management Inc. trimmed its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 10,263 shares of the company’s stock after selling 282 shares during the quarter. Traynor Capital Management Inc.’s holdings […]